MediciBIO
Yongin, Ch'ungch'ong-namdo, South Korea
About MediciBIO
MediciBIO primarily focuses on developing novel gene therapy technology by converging knowledge in the field of genetic biotechnology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Corporate Round (Dec 2024)
- Website: medicibio.com
- Phone: +82-31-895-6710
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/medicibio-2531506 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.